Regulatory clearances, partnerships, awards and milestones from Phantomics.
Phantomics has obtained Class 3 digital medical device manufacturing approval from Korea's MFDS for Angiomics ER, coronary CT stenosis diagnostic-support software that helps prioritize care for emergency chest-pain patients.
Read morePhantomics, a leading medical imaging AI company (CEOs Byungwook Choi and Pan Kim), has signed a strategic partnership agreement with Philmedis Clinic (Director Namsik Jung) for research collaboration based on cardiac MRI.Through this agreement, Phantomics sec
Read moreStrategic MOU aims to enhance clinical accuracy and real-world application of heart disease AIPhantomics, a South Korean medical AI company, has signed a memorandum of understanding (MOU) with Yonsei University’s School of Digital Healthcare to jointly develop
Read moreStrategic Partnership with Hwajeong Hospital Enables Broader Clinical AdoptionPhantomics, a South Korean medical AI company, has signed a strategic partnership (MOU) with Hwajeong Hospital to deploy its AI-powered cardiac MRI analysis solution, Myomics, in gen
Read morePhantomics’ Myomics AI transforms cardiac MRI diagnosticsPhantomics, a South Korean medical AI startup, has developed Myomics, an AI-powered cardiac MRI analysis solution that can detect heart disease in under 5 minutes, a breakthrough in diagnostic speed and
Read moreMyomics recognized for transforming cardiac MRI into a virtual biopsyPhantomics, a leading medical AI company, has been awarded the KHF 2025 Innovation Award for its groundbreaking cardiac MRI analysis solution, Myomics.Myomics is the world’s first AI solution
Read moreAI-powered cardiac MRI solution enters Asian market with regulatory approvalPhantomics, a South Korean medical AI company, announced that its cardiac MRI analysis solution Myomics has received Class II medical device certification from Japan’s Pharmaceuticals
Read more10-minute non-contrast MRI solution aims to transform premium health checkupsPhantomics, a South Korean medical AI company, has signed a strategic memorandum of understanding (MOU) with Yujeong Meditech, a leading medical device distributor, to introduce a pre
Read morePartnership aims to enhance cardiac MRI efficiency with AI-powered diagnosticsGE HealthCare Korea has signed a memorandum of understanding (MOU) with Phantomics, a South Korean medical AI startup specializing in cardiac imaging, to improve the efficiency and a
Read morePhatomics, a leading Korean medical AI startup, has entered a strategic partnership with Siemens Healthineers to promote the adoption of AI-based cardiac imaging solutions, Myomics and Angiomics, across hospitals in Korea and internationally.This collaboration
Read morePhantomics, in collaboration with Prof. Jin Hur (Department of Radiology, Severance Hospital) and Prof. Jin-Young Kim (Keimyung University Dongsan Hospital), has developed a deep-learning model that not only detects coronary artery disease (CAD) on CT angiogra
Read moreStrategic MOU to Advance AI-Powered Cardiac Imaging📍 OverviewPhantomics Inc., a deep-tech startup in medical imaging AI, has signed an MOU with Severance Cardiovascular Hospital, Korea’s top-tier heart care center. This partnership aims to accelerate clinical
Read moreMOU Signed to Advance AI-Driven Cardiac Imaging Research📍 OverviewPhantomics Inc., a leading cardiac imaging AI startup, has entered into a strategic research MOU with K-MEDI HUB (Korea’s Advanced Medical Industry Promotion Foundation) to jointly develop next-
Read morePhantomics has signed an MOU with Severance Cardiovascular Hospital for AI research and technology development, including joint studies to strengthen the clinical utility of Myomics and Angiomics and to develop heart-disease prediction models.
Read morePhantomics, a leading medical imaging AI company (Co-CEOs Byung Wook Choi and Pan Ki Kim), announced that it has received FDA 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the enhanced version of its AI-based cardiac MRI analysis soluti
Read morePhantomics, a leading medical imaging AI company (Co-CEOs Byungwook Choi and Panki Kim), announced that it has supplied Myomics, an AI-powered cardiac MRI analysis and diagnosis solution, to Severance Hospital.Myomics is an AI solution designed to analyze card
Read morePhantomics has signed a memorandum of understanding with Flownix, a developer of MRI-based blood-flow analysis software, to advance cardiac MRI technology and broaden its adoption through joint R&D and marketing cooperation.
Read morePhantomics announced that Myomics, its cardiac MRI innovation solution, has been selected for the Seoul Awards 2024, a product-certification program run by the Seoul Business Agency to support overseas market development and export growth.
Read moreMedical imaging AI company Phantomics is partnering with the Cardiac Imaging Center at Asan Medical Center’s Heart Institute to develop a new protocol aimed at popularizing cardiac MRI.Phantomics announced hat it has signed a radiological consulting agreement
Read morePhantomics has signed an agreement with the Seoul Metropolitan Government to carry out the 2025 Seoul-type Strong SME support program, receiving two years of support from January 2025 through the end of 2026.
Read more"Our mission is to expand the adoption of cardiac MRI and CT solutions, enabling precise and efficient heart disease diagnosis from advanced general hospitals to routine health checkups," said CEO Pan Ki Kim.On the 25th, CEO Pan Ki Kim shared the inspiration b
Read morePhantomics has been selected as a TIPS (Tech Incubator Program for Startups) Global Marketing company by Korea's Ministry of SMEs and Startups, a program that funds overseas expansion for startups with strong global potential.
Read morePhantomics announced that it won the Silver Award in the Oral Presentation category of the Best Trainee Scientific Awards at the 12th International Congress on Magnetic Resonance Imaging (ICMRI 2024). The award was presented to Jae-Yoon Shim, Senior Researcher
Read morePhantomics announced that it received the Best Innovation Technology Award at the FIX 2024 Innovation Awards.The FIX Innovation Awards recognize products with outstanding innovation, technological excellence, and market potential among innovative technologies
Read morePhantomics announced the successful completion of its 1st User Summit – 2024 CMR Symposium, held on October 11. The event was organized for cardiologists and radiologists to engage with the company’s flagship MRI-based cardiac disease diagnosis AI solution, My
Read morePhantomics announced the successful completion of a joint seminar with the research team of Professor Jonghye Woo from the Department of Radiology at Massachusetts General Hospital (MGH) on September 25.Under the theme “Advancing AI Together: Celebrating the G
Read morePhantomics announced that it has received regulatory approval from Malaysia's regulatory authority, the Medical Device Authority Malaysia (MDA Malaysia), for its non-invasive cardiac disease diagnosis solution 'Myomics.' With this approval, Phantomics plans to
Read morePhantomics, a leader in medical artificial intelligence(AI), announced that it has won the CES 2024 Innovation Award for its medical imaging AI technology.Phantomics received the award for its medical AI solution, "Myomics." Myomics is a non-invasive heart MRI
Read more